Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Public Health|June 5, 2026
Central auditory tests reveal deficits in HIV treatmentAbby K Kambhampaty, Christopher E Niemczak, Robert A Hill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2016
Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized TrialLinda Barlow-Mosha, Konstantia Angelidou, Jane Lindsey, et al.
The Journal of Infectious Diseases|February 28, 2002
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposureJoan H Skurnick, Paul Palumbo, Anthony DeVico, et al.
Archives of Pediatrics & Adolescent Medicine|October 7, 2004
Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocolSusan Schuval, Russell B Van Dyke, Jane C Lindsey, et al.
The New England Journal of Medicine|October 15, 2010
Antiretroviral treatment for children with peripartum nevirapine exposurePaul Palumbo, Jane C Lindsey, Michael D Hughes, et al.
The American Journal of Tropical Medicine and Hygiene|November 23, 2017
Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral TherapyCharlotte V Hobbs, Erin E Gabriel, Portia Kamthunzi, et al.
The Pediatric Infectious Disease Journal|September 16, 2014
Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmissionJane C Lindsey, Michael D Hughes, Avy Violari, et al.
The New England Journal of Medicine|June 22, 2012
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected childrenAvy Violari, Jane C Lindsey, Michael D Hughes, et al.
Plos One|December 10, 2016
Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060Charlotte V Hobbs, Erin E Gabriel, Portia Kamthunzi, et al.
The Pediatric Infectious Disease Journal|May 7, 2005
GB virus C infection in children with perinatal human immunodeficiency virus infectionSusan Schuval, Jane C Lindsey, Jack T Stapleton, et al.
Pageof 6